Header Ads

Covid is giving us some ugly choices

Bloomberg Opinion Today
Bloomberg

Life is a series of choices — or trade-offs, depending on how you look at it. The novel coronavirus sprung upon us choices few of us thought we'd have to confront in our lifetimes. The same goes for governments, which had to decide on lockdown philosophies (total? Partial? How long?) and social distancing rules. The miracle vaccine some are desperate to acquire poses a nightmare for others. What works in one country is anathema in another. And this week's easy choice might not make sense the next: Today's promising treatment for Covid-19 could come at too high a cost tomorrow; closing schools indefinitely to stop an outbreak means years of economic harm for students and nations alike. Making choices in the era of Covid-19 isn't just about fighting a virus; our moral code, our ethics and our humanity are also at stake.

Can You Handle Herd Immunity? Ask These Philosophers — John Authers

Boris Johnson Confronts a Swedish Obsession — Therese Raphael

"Long Covid" Makes the Pandemic Even Scarier — Andreas Kluth

Being Irresponsible About Covid Isn't the Main Problem — Tyler Cowen

A Coronavirus Vaccine Is Coming, So Who Gets It First? — Mark Buchanan

A Crisis Warning Is in Danger of Being Forgotten — Daniel Moss

The Truth About Trump's Covid-19 Cocktail 'Cure' — Max Nisen

Madrid, Marseille and Middlesbrough Highlight New Virus Problem — Ferdinando Giugliano

Colleges Are Better at Covid-19 Testing Than the White House — Faye Flam

Are Hospitals Ready For Covid's Second Wave? — Lionel Laurent

This is the Theme of the Week edition of Bloomberg Opinion Today, a digest of our top commentary published every Sunday.

 

Like Bloomberg Opinion Today? Subscribe to Bloomberg All Access and get much, much more. You'll receive our unmatched global news coverage and two in-depth daily newsletters, The Bloomberg Open and The Bloomberg Close.

Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. Learn more.

 

No comments